Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

Similar articles for PubMed (Select 22204908)

1.

New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships.

Saify ZS, Azim MK, Ahmad W, Nisa M, Goldberg DE, Hussain SA, Akhtar S, Akram A, Arayne A, Oksman A, Khan IA.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1282-6. doi: 10.1016/j.bmcl.2011.10.018. Epub 2011 Oct 20.

PMID:
22204908
2.

Identification of acridinyl hydrazides as potent aspartic protease inhibitors.

Azim MK, Ahmed W, Khan IA, Rao NA, Khan KM.

Bioorg Med Chem Lett. 2008 May 1;18(9):3011-5. doi: 10.1016/j.bmcl.2008.02.060. Epub 2008 Feb 29.

PMID:
18417344
3.

Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.

Mohapatra SC, Tiwari HK, Singla M, Rathi B, Sharma A, Mahiya K, Kumar M, Sinha S, Chauhan SS.

J Biol Inorg Chem. 2010 Mar;15(3):373-85. doi: 10.1007/s00775-009-0610-9. Epub 2009 Nov 28.

PMID:
19946719
4.

Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors.

Ahmed W, Rani M, Khan IA, Iqbal A, Khan KM, Haleem MA, Azim MK.

J Enzyme Inhib Med Chem. 2010 Oct;25(5):673-8. doi: 10.3109/14756360903508430.

PMID:
20063996
5.

Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.

Haque TS, Skillman AG, Lee CE, Habashita H, Gluzman IY, Ewing TJ, Goldberg DE, Kuntz ID, Ellman JA.

J Med Chem. 1999 Apr 22;42(8):1428-40.

PMID:
10212129
6.

Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.

Gupta D, Yedidi RS, Varghese S, Kovari LC, Woster PM.

J Med Chem. 2010 May 27;53(10):4234-47. doi: 10.1021/jm100233b.

PMID:
20438064
7.

Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.

Li T, Yowell CA, Beyer BB, Hung SH, Westling J, Lam MT, Dunn BM, Dame JB.

Mol Biochem Parasitol. 2004 May;135(1):101-9.

PMID:
15287591
8.
9.

Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II.

Dahlgren A, Kvarnström I, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B.

Bioorg Med Chem. 2003 Mar 20;11(6):827-41.

PMID:
12614868
10.

Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.

Dali B, Keita M, Megnassan E, Frecer V, Miertus S.

Chem Biol Drug Des. 2012 Apr;79(4):411-30. doi: 10.1111/j.1747-0285.2011.01276.x.

PMID:
22129033
11.

Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.

Luksch T, Chan NS, Brass S, Sotriffer CA, Klebe G, Diederich WE.

ChemMedChem. 2008 Sep;3(9):1323-36. doi: 10.1002/cmdc.200700270.

PMID:
18752222
12.

De Novo design, synthesis, and in vitro evaluation of a new class of nonpeptidic inhibitors of the malarial enzyme plasmepsin II.

Carcache DA, Hörtner SR, Bertogg A, Binkert C, Bur D, Märki HP, Dorn A, Diederich F.

Chembiochem. 2002 Nov 4;3(11):1137-41. No abstract available.

PMID:
12404641
13.

Inhibitors of Plasmepsin II-potential antimalarial agents.

Corminboeuf O, Dunet G, Hafsi M, Grimont J, Grisostomi C, Meyer S, Binkert C, Bur D, Jones A, Prade L, Brun R, Boss C.

Bioorg Med Chem Lett. 2006 Dec 15;16(24):6194-9. Epub 2006 Sep 26.

PMID:
17000102
14.

Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.

Johansson PO, Chen Y, Belfrage AK, Blackman MJ, Kvarnström I, Jansson K, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B.

J Med Chem. 2004 Jun 17;47(13):3353-66.

PMID:
15189032
15.

Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.

Ersmark K, Feierberg I, Bjelic S, Hamelink E, Hackett F, Blackman MJ, Hultén J, Samuelsson B, Aqvist J, Hallberg A.

J Med Chem. 2004 Jan 1;47(1):110-22.

PMID:
14695825
16.

New potent C2-symmetric malaria plasmepsin I and II inhibitors.

Oscarsson K, Oscarson S, Vrang L, Hamelink E, Hallberg A, Samuelsson B.

Bioorg Med Chem. 2003 Apr 3;11(7):1235-46.

PMID:
12628651
17.

Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.

Carroll CD, Patel H, Johnson TO, Guo T, Orlowski M, He ZM, Cavallaro CL, Guo J, Oksman A, Gluzman IY, Connelly J, Chelsky D, Goldberg DE, Dolle RE.

Bioorg Med Chem Lett. 1998 Sep 8;8(17):2315-20.

PMID:
9873534
18.

High antiplasmodial activity of novel plasmepsins I and II inhibitors.

Dell'Agli M, Parapini S, Galli G, Vaiana N, Taramelli D, Sparatore A, Liu P, Dunn BM, Bosisio E, Romeo S.

J Med Chem. 2006 Dec 14;49(25):7440-9.

PMID:
17149873
19.

[Selective inhibitors of plasmepsin II from Plasmodium falciparum based on pepstatin].

Rumsh LD, Mikhaĭlova AG, Mikhura IV, Prudchenko IA, Chikin LD, Mikhaleva II, Kaliberda EN, Dergousova NI, Mel'nikov EE, Formanovskiĭ AA.

Bioorg Khim. 2008 Nov-Dec;34(6):739-46. Russian.

PMID:
19088746
20.

Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.

Ersmark K, Nervall M, Gutiérrez-de-Terán H, Hamelink E, Janka LK, Clemente JC, Dunn BM, Gogoll A, Samuelsson B, Qvist J, Hallberg A.

Bioorg Med Chem. 2006 Apr 1;14(7):2197-208. Epub 2005 Nov 22.

PMID:
16307884
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk